3 completed, 2 active not recruiting, 1 withdrawn. 2 Phase 2, 1 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
| Early Phase 1 | 1 | Active not recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Andrew Hendifar, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma Ketorolac Tromethamine - Pancreas Cancer, Pancreatic Ductal Adenocarcinoma | Early Phase 1 | Active not recruiting | Andrew Hendifar, MD | 28 | 2022-07-01 | 2026-10-20 |
| Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma Telatinib, Keytruda - Gastric Cancer, Hepatocellular Carcinoma | Phase 2 | Completed | Andrew Hendifar, MD | 16 | 2021-07-28 | 2025-12-11 |
| Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency Pancrelipase - Pancreatic Adenocarcinoma | Phase 2 | Active not recruiting | Andrew Hendifar, MD | 36 | 2020-12-17 | 2026-01-23 |
| Open Label Study to Analyze the Effect of Telotristat Ethyl on Weight Regulation/Gain telotristat ethyl - Pancreatic Cancer, Neuroendocrine Tumors | Withdrawn | Andrew Hendifar, MD | 2020-10-01 | 2020-12-30 | ||
| Study of Onivyde and 5-FU in Combination With Xilonix for Pancreatic Cancer With Cachexia Xilonix plus Onivyde and 5FU - Pancreatic Cancer, Cachexia | Phase 1 | Completed | Andrew Hendifar, MD | 16 | 2017-10-16 | 2020-12-30 |
| Evaluating Weight Stability of Pancreatic Cancer Cachexia Patients Tube feeding - Pancreatic Neoplasms, Pancreatic Cancer | Completed | Andrew Hendifar, MD | 30 | 2015-04-27 | 2020-08-11 |
Pancreatic Neoplasms (4) · Cachexia (3) · Weight Loss (2) · Adenocarcinoma (1) · Carcinoma, Hepatocellular (1) · Disease (1) · Neoplasms (1) · Neuroendocrine Tumors (1) · Stomach Neoplasms (1)
Enteral Nutrition (1) · Fluorouracil (1) · Ketorolac Tromethamine (1) · Pancrelipase (1) · bermekimab (1) · irinotecan sucrosofate (1) · pembrolizumab (1) · telatinib (1) · telotristat ethyl (1)
United States (5)